Cross Shawn

Chief Financial Officer at PCRX; CEO & Chair of the Board at Applied Molecular Transport Inc.

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
13
Latest Apr 23, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Sep 5, 2023 2023

    Sold 5,559 shares at $0.23 ($1k)

    Cross Shawn, CEO & Chair of the Board

    No 10b5-1 planSold 0.7% of holdings ($175k position)746,748 shares left1.4x usual sizeFiling

  2. Sep 29, 2023 +24 days

    Sold 193,960 shares at $0.16 ($31k)

    Cross Shawn, CEO & Chair of the Board

    No 10b5-1 planSold 20.5% of holdings ($151k position)752,307 shares left80.4x usual sizeFiling

  3. Nov 15, 2023 +47 days

    Sold 90,447 shares at $0.16 ($14k)

    Cross Shawn, CEO & Chair of the Board

    No 10b5-1 planSold 12.1% of holdings ($119k position)656,301 shares left23.1x usual sizeFiling

  4. Nov 22, 2023 +7 days

    Sold 110,802 shares at $0.16 ($18k)

    Cross Shawn, CEO & Chair of the Board

    No 10b5-1 planSold 16.9% of holdings ($105k position)545,499 shares left28.2x usual sizeFiling

  5. 5 Form 4 sale PCRXRoutine
    Nov 10, 2025 +719 days

    Sold 12,060 shares at $22.09 ($266k)

    Cross Shawn, Chief Financial Officer

    10b5-1 planSold 17.7% of holdings ($1.5M position)56,250 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale PCRXRoutine
    Dec 10, 2025 +30 days

    Sold 25,000 shares at $25.07 ($627k)

    Cross Shawn, Chief Financial Officer

    10b5-1 planSold 30.8% of holdings ($2M position)56,250 shares leftFiling

  7. 7 Form 4 sale PCRXRoutine
    Apr 22, 2026 +133 days

    Sold 12,059 shares at $25.09 ($303k)

    Cross Shawn, Chief Financial Officer

    10b5-1 planSold 10.3% of holdings ($2.9M position)105,341 shares leftFiling

  8. 8 Form 4 sale PCRXRoutine
    Apr 23, 2026 +1 day

    Sold 12,941 shares at $25.16 ($326k)

    Cross Shawn, Chief Financial Officer

    10b5-1 planSold 10.9% of holdings ($3M position)105,341 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Cross Shawn
Source
Apr 23, 2026Apr 24, 2026PCRXChief Financial OfficerForm 4 sale12,941$326k10.9%RoutineSEC
Apr 22, 2026Apr 22, 2026PCRXChief Financial OfficerForm 4 sale12,059$303k10.3%RoutineSEC
Dec 10, 2025Dec 11, 2025PCRXChief Financial OfficerForm 4 sale25,000$627k30.8%RoutineSEC
Nov 10, 2025Nov 13, 2025PCRXChief Financial OfficerForm 4 sale12,060$266k17.7%RoutineSEC
Nov 22, 2023Nov 24, 2023Applied Molecular Transport Inc.CEO & Chair of the BoardForm 4 sale110,802$18k16.9%UnusualSEC
Nov 15, 2023Nov 16, 2023Applied Molecular Transport Inc.CEO & Chair of the BoardForm 4 sale90,447$14k12.1%UnusualSEC
Sep 29, 2023Oct 2, 2023Applied Molecular Transport Inc.CEO & Chair of the BoardForm 4 sale193,960$31k20.5%UnusualSEC
Sep 5, 2023Oct 4, 2023Applied Molecular Transport Inc.CEO & Chair of the BoardForm 4 sale5,559$1k0.7%No planSEC
Mar 1, 2023Mar 3, 2023Applied Molecular Transport Inc.President & COOForm 4 sale934$4671.5%Plan not statedSEC
Dec 2, 2022Dec 6, 2022Applied Molecular Transport Inc.President & COOForm 4 sale3,893$4k6.0%Plan not statedSEC
Sep 1, 2022Sep 6, 2022Applied Molecular Transport Inc.President & COOForm 4 sale884$1k1.3%Plan not statedSEC
Jun 2, 2022Jun 3, 2022Applied Molecular Transport Inc.President & COOForm 4 sale3,933$12k5.6%Plan not statedSEC
Aug 23, 2021Aug 23, 2021Applied Molecular Transport Inc.Chief Financial OfficerForm 4 sale10,000$301k100.0%UnusualSEC